You have 9 free searches left this month | for more free features.

KPT-330

Showing 26 - 50 of 198

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)

Completed
  • Ovarian Cancer
  • Endometrial Cancer
  • Middletown, New Jersey
  • +2 more
Apr 22, 2021

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
Aug 1, 2021

Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 7, 2022

Prostate Cancer Trial in Houston (Selinexor)

Terminated
  • Prostate Cancer
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 7, 2021

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
  • Hematological Malignancies
  • KPT-330
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Solid Tumors Trial in Singapore (KPT-330)

Completed
  • Solid Tumors
  • KPT-330
  • Singapore, Singapore
    National University Hospital
Sep 8, 2020

Breast Cancer Trial in Tampa (Selinexor)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)

Completed
  • B-cell Lymphoma
  • Bruxelles, Belgium
  • +7 more
Dec 6, 2021

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
  • Coronavirus Infection
  • Los Angeles, California
  • +32 more
Oct 27, 2021

Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

Recruiting
  • Locally Advanced Unresectable or Metastatic Melanoma
  • Los Angeles, California
  • +12 more
Jun 30, 2022

Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)

Suspended
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Tucson, Arizona
  • +17 more
Jan 24, 2023

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Squamous Cell Carcinoma Trial in Canada, United States (Selinexor (KPT-330))

Terminated
  • Squamous Cell Carcinoma
  • Selinexor (KPT-330)
  • Aurora, Colorado
  • +17 more
Nov 6, 2020